Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial
- Author
- OETTLE, Helmut1 ; NEUHAUS, Peter2 ; SINN, Marianne1 ; HINKE, Axel11 ; RIESS, Hanno1 ; HOCHHAUS, Andreas3 ; HARTMANN, Jörg Thomas4 ; GELLERT, Klaus5 ; RIDWELSKI, Karsten6 ; NIEDERGETHMANN, Marco7 ; ZÜLKE, Carl8 ; FAHLKE, Jörg9 ; ARNING, Michael B10
[1] Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité―Universitätsmedizin Berlin, Berlin, Germany
[2] Klinik für Allgemein-, Visceral- und Transplantationschirurgie, Charité―Universitätsmedizin Berlin, Germany
[3] Klinik für Innere Medizin II, Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany
[4] Klinik Innere II―Hämatologie und Onkologie, Universitätsklinikum Schleswig-Holstein, Christian-Albrechts-Universität zu Kiel, Kiel, Germany
[5] Klinik für Allgemein- u. Viszeralchirurgie, Oskar-Ziethen-Krankenhaus, Berlin, Germany
[6] Klinik für Allgemein- und Viszeralchirurgie, Städtisches Klinikum Magdeburg, Magdeburg, Germany
[7] Chirurgische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany
[8] Klinik für Chirurgie: Allgemein- und Viszeralchirurgie, Marienhospital Gelsenkirchen GmbH, Gelsenkirchen, Germany
[9] Klinik für Allgemein-, Viszeral- und Gefässchirurgie, Universitätsklinikum Magdeburg, Magdeburg, Germany
[10] Oncology Medicines Development Center, GlaxoSmithKline, Collegeville, Pennsylvania, United States
[11] WiSP Research Institute, Langenfeld, Germany - Source
JAMA, the journal of the American Medical Association. 2013, Vol 310, Num 14, pp 1473-1481, 9 p ; ref : 29 ref
- ISSN
- 0098-7484
- Scientific domain
- General medicine general surgery
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancer du pancréas Chimiothérapie Essai clinique Evolution Gemcitabine Homme Long terme Malade Médecine Pronostic Résection chirurgicale Traitement adjuvant Antimétabolite Cancer Chirurgie Dérivé de la pyrimidine Fluor Composé organique Pathologie de l'appareil digestif Pathologie du pancréas Pyrimidine nucléoside Traitement Tumeur maligne
- Keyword (en)
- Antineoplastic agent Pancreas cancer Chemotherapy Clinical trial Evolution Gemcitabine Human Long term Patient Medicine Prognosis Surgical resection Adjuvant treatment Antimetabolic Cancer Surgery Pyrimidine derivatives Fluorine Organic compounds Digestive diseases Pancreatic disease Pyrimidine nucleoside Treatment Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del páncreas Quimioterapia Ensayo clínico Evolución Gemcitabina Hombre Largo plazo Enfermo Medicina Pronóstico Resección quirúrgica Tratamiento adyuvante Antimetabólito Cáncer Cirugía Pirimidina derivado Fluor Compuesto orgánico Aparato digestivo patología Páncreas patología Pirimidina nucleósido Tratamiento Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27799149
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/jama.2013.279201 
https://dx.doi.org/10.1001/jama.2013.279201
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"310\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1481\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OETTLE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Helmut\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"NEUHAUS, Peter\";i:1;s:14:\"SINN, Marianne\";i:2;s:11:\"HINKE, Axel\";i:3;s:12:\"RIESS, Hanno\";i:4;s:17:\"HOCHHAUS, Andreas\";i:5;s:22:\"HARTMANN, J\u00f6rg Thomas\";i:6;s:14:\"GELLERT, Klaus\";i:7;s:18:\"RIDWELSKI, Karsten\";i:8;s:21:\"NIEDERGETHMANN, Marco\";i:9;s:12:\"Z\u00dcLKE, Carl\";i:10;s:13:\"FAHLKE, J\u00f6rg\";i:11;s:17:\"ARNING, Michael B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"310\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1481\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OETTLE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Helmut\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"NEUHAUS, Peter\";i:1;s:14:\"SINN, Marianne\";i:2;s:11:\"HINKE, Axel\";i:3;s:12:\"RIESS, Hanno\";i:4;s:17:\"HOCHHAUS, Andreas\";i:5;s:22:\"HARTMANN, J\u00f6rg Thomas\";i:6;s:14:\"GELLERT, Klaus\";i:7;s:18:\"RIDWELSKI, Karsten\";i:8;s:21:\"NIEDERGETHMANN, Marco\";i:9;s:12:\"Z\u00dcLKE, Carl\";i:10;s:13:\"FAHLKE, J\u00f6rg\";i:11;s:17:\"ARNING, Michael B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"310\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1481\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OETTLE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Helmut\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"NEUHAUS, Peter\";i:1;s:14:\"SINN, Marianne\";i:2;s:11:\"HINKE, Axel\";i:3;s:12:\"RIESS, Hanno\";i:4;s:17:\"HOCHHAUS, Andreas\";i:5;s:22:\"HARTMANN, J\u00f6rg Thomas\";i:6;s:14:\"GELLERT, Klaus\";i:7;s:18:\"RIDWELSKI, Karsten\";i:8;s:21:\"NIEDERGETHMANN, Marco\";i:9;s:12:\"Z\u00dcLKE, Carl\";i:10;s:13:\"FAHLKE, J\u00f6rg\";i:11;s:17:\"ARNING, Michael B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"310\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1481\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OETTLE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Helmut\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"NEUHAUS, Peter\";i:1;s:14:\"SINN, Marianne\";i:2;s:11:\"HINKE, Axel\";i:3;s:12:\"RIESS, Hanno\";i:4;s:17:\"HOCHHAUS, Andreas\";i:5;s:22:\"HARTMANN, J\u00f6rg Thomas\";i:6;s:14:\"GELLERT, Klaus\";i:7;s:18:\"RIDWELSKI, Karsten\";i:8;s:21:\"NIEDERGETHMANN, Marco\";i:9;s:12:\"Z\u00dcLKE, Carl\";i:10;s:13:\"FAHLKE, J\u00f6rg\";i:11;s:17:\"ARNING, Michael B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1001\/jama.2013.279201\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"310\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1481\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OETTLE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Helmut\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:14:\"NEUHAUS, Peter\";i:1;s:14:\"SINN, Marianne\";i:2;s:11:\"HINKE, Axel\";i:3;s:12:\"RIESS, Hanno\";i:4;s:17:\"HOCHHAUS, Andreas\";i:5;s:22:\"HARTMANN, J\u00f6rg Thomas\";i:6;s:14:\"GELLERT, Klaus\";i:7;s:18:\"RIDWELSKI, Karsten\";i:8;s:21:\"NIEDERGETHMANN, Marco\";i:9;s:12:\"Z\u00dcLKE, Carl\";i:10;s:13:\"FAHLKE, J\u00f6rg\";i:11;s:17:\"ARNING, Michael B\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:140:\"Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer: The CONKO-001 Randomized Trial\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
